The FDA has just approved a new non-opioid analgesic to treat acute pain. The P&T Committee has already received a request to add this medication to the formulary. In addition to standard review of efficacy, safety, and place in therapy, which approach is the BEST way for the committee to determine this medication’s utility? A. Focus on regulatory and compliance implications and benefit design B. Focus on the plan’s membership and recent analgesic use C. Focus on value-based assessment using cost effectiveness analysis D. Add the new medication immediately with a prior authorization requirement
[Verified Answer]: The FDA has just approved a new non-opioid…
Need help with your Pain Management & Analgesics case study or NCLEX preparation? Connect with a verified Nursing expert now.